#20. Ensifentrine's Triumph: An AI Blueprint for Drug Development
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
#20. Ensifentrine's Triumph: An AI Blueprint for Drug Development
-
Narrated by:
-
By:
About this listen
This podcast examines Verona Pharma's ensifentrine, a drug for Chronic Obstructive Pulmonary Disease (COPD), as a case study for AI-driven drug development. It highlights how the company's strategic choices, from the drug's unique "Goldilocks" molecular profile to its targeted delivery method, broad clinical trial design, and niche commercial strategy, led to its successful FDA approval and a multi-billion dollar acquisition. The podcast then details how AI can replicate and enhance these successes across various stages, including molecule design, patient stratification, clinical trial optimization, and commercial strategy, offering a blueprint for future AI-powered pharmaceutical ventures. Produced by Dr. Jake Chen.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.